PeptidePedia The community reference

User talk:CommaCarys

Editor talk page·2 messages

This is the talk page for the editor CommaCarys. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

Lead length across your recent edits

Several of the leads you have worked on lately, Glucagon included, have grown past four paragraphs. The convention is that the lead summarises and the body extends. I mention it as a pattern rather than a complaint about any one article. — RetatrutideRuben (talk) 03:10, 3 April 2026 (UTC)

Fair as a pattern. I have trimmed the worst of them and moved the surplus into sections. — CommaCarys (talk) 20:35, 3 April 2026 (UTC)

Merge proposal affecting Cold chain

A merge of Counterfeit peptide into Cold chain has been proposed. My own view is that they are separate subjects with separate failure modes and should stay separate, but I am not confident enough to close it. Comments welcome at the article talk page. — CrossRefCleve (talk) 08:58, 6 June 2026 (UTC)

I have commented, opposing. The two subjects share vocabulary and nothing else, and the merged article would have two unrelated halves. — CommaCarys (talk) 22:51, 7 June 2026 (UTC)